Adrenergic, dopaminergic and serotonergic gene expression in low dose, long time insulin and somatotropin treatment to ageing rats: Rejuvenation of brain function

Biogerontology

Volumn 9, Issue 6, 2008, Pages 429-439

  Paulose, C S ^a   Balakrishnan, Savitha ^a  

^a Department of Physics   (India)

Author keywords

Adrenergic; Ageing; Dopaminergic; Insulin and somatotropin; Rejuvenation; Serotonergic

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; GROWTH HORMONE; INSULIN; INSULIN ZINC SUSPENSION; SEROTONIN; SEROTONIN 2C RECEPTOR; SODIUM CHLORIDE;

ADRENERGIC SYSTEM; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN STEM; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; GENE EXPRESSION; LOW DRUG DOSE; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REJUVENATION; SEROTONINERGIC SYSTEM;

AGING; ANIMALS; BRAIN; BRAIN STEM; CEREBRAL CORTEX; CORPUS STRIATUM; GENE EXPRESSION; GROWTH HORMONE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; REJUVENATION;

EID: 56049084627     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-008-9183-1     Document Type: Conference Paper

References (42)

1. Abraham A, Paulose CS (1999) Age-related alterations in noradrenergic function in the brainstem of streptozotocin-diabetic rats. J Biochem Mol Biol Biophys 3:171-176
2. Ajo R, Cacicdeo L, Gonzsalex B, Sanchez-Franco F (2001) Growth Hormone stimulates proliferation and differentiation of embryonic brain cells via MAP/ERK signaling pathways. In: Abstracts of 83rd annual meeting of endocrine society, pp 1-28
3. Arianna R, Silvia M, Alberto O, Andrea M (2007) D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice. Neuropsychopharmacology 32:309-319
4. Bartke A (2006) Long-lived Klotho mice: New insights into the roles of IGF-1 and insulin in aging. Trends Endocrinol Metab 17:33-35
5. Ben-Jonathan N, Hnasko R (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724-763
6. Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten AF (1999) A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry 46:1266-1274
7. Bücheler MM, Hadamek K, Hein L (2002) Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience 109:819-826
8. Burke MR, Barnes GR (2006) Quantitative differences in smooth pursuit and saccadic eye movements. Exp Brain Res 175:596-608
9. Cristina C, Díaz-Torga G, Baldi A, Góngora A, Rubinstein M, Low MJ, Becú Villalobos D (2005) Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice. Endocrinology 146:2952-2962
10. Díaz-Torga G, Feierstein C, Libertun C, Gelman D, Kelly MA, Low MJ, Rubinstein M, Becú-Villalobos D (2002) Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology 143:1270-1279
11. Eswar Shankar PN, Joseph A, Paulose CS (2007) Decreased [3H] YM-09151-2 binding to dopamine D2 receptors in the hypothalamus, brainstem and pancreatic islets of streptozotocin-induced diabetic rats. Eur J Pharmacol 557:99-105
12. Geinisman Y, de Toledo-Morrell L, Morrell F, Persina IS, Rossi M (1992) Age-related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector technique. Hippocampus 2:437-444
13. Ghigo E, Bartolotta E, Imperiale E, Bellone J, Cardinale G, Aimaretti G, Valetto MR, Cherubini V, Maccario M, Cocchi D et al (1994) Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest 17:849-854
14. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797. doi: 10.1210/er.19.6.717
15. 3H] DOPA in various regions of the brain. J Neurochem 13:655-669. doi: 10.1111/j.1471-4159.1966.tb09873.x
16. Guillod-Maximin E, Lorsignol A, Alquier T, Penicaud L (2004) Acute intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei: Involvement of astrocytes in cerebral glucose-sensing in rats. J Neuroendocrinol 16:464-471
17. Hafen E (2004) Cancer, type 2 diabetes, and ageing: News from flies and worms. Swiss Med Wkly 134:711-719
18. Harvey S, Lavelin I, Pines M (2002) Growth hormone (GH) action in the brain: Neural expression of a GH-response gene. J Mol Neurosci 18:89-95. doi: 10.1385/JMN:18:1-2:89
19. Jaffe CA, Barkan AL (1992) Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am 21:713-735
20. Jaffe CA, DeMott-Friberg R, Barkan AL (1996) Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli. J Clin Invest 97:934-940. doi: 10.1172/JCI118516
21. Martin JB (1973) Functions of the hypothalamus and amygdala in regulation of growth hormone secretion. Trans Am Neurol Assoc 98:229-232
22. Minamitani N, Chihara K, Kaji H, Kodama H, Kita T, Fujita T (1989) Alpha 2 adrenergic control of growth hormone (GH) secretion in conscious male rabbits: Involvement of endogenous GH-releasing factor and somatostatin. Endocrinology 125:2839-2845
23. Mizoguchi H, Narita M, Wu H, Narita M, Suzuki T, Nagase H, Tseng LF (2000) Differential involvement of mu (1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla. Neuroscience 100:835-839
24. Morrione A, Valentinis B, Shi-qiong X, Yumet G, Louvi A, Efstratiadis A, Baserga R (1997) Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci USA 94:3777-3782. doi: 10.1073/pnas.94.8.3777
25. Müller EE (1987) Neural control of somatotropic function. Physiol Rev 67:962-1053
26. Mustafa A, Sharma HS, Olsson Y, Gordh T, Thóren P, Sjöquist PO, Roos P, Adem A, Nyberg F (1995) Vascular permeability to growth hormone in the rat central nervous system after focal spinal cord injury. Influence of a new anti oxidant H 290/51 and age. Neurosci Res 23:185-194. doi: 10.1016/0168-0102(95)00937-O
27. Nicholson DA, Yoshida R, Berry RW, Gallagher M, Geinisman Y (2004) Reduction in size of perforated postsynaptic densities in hippocampal axospinous synapses and age-related spatial learning impairments. J Neurosci 24:7648-7653
28. Nonogaki K (2000) New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:533-549
29. Noriyuki K, Masakatsu K, Tadao K, Mitsuo S (1989) Electrical stimulation of specific brainstem nuclei suppresses growth hormone-releasing hormone-induced growth hormone secretion in the pentobarbital anaesthetized rat. J Neuroendocrinol 1:209-214
30. Padayatti PS, Paulose CS (1999) Alpha2 adrenergic and high affinity serotonergic receptor changes in the brain stem of streptozotocin-induced diabetic rats. Life Sci 65:403-414
31. Papageorgiou A, Denef C (2007) Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: Evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors. Endocrinology 148:4509-4522
32. Paulose CS, Dakshinamurti K, Packer S, Stephens NL (1988) Sympathetic stimulation and hypertension in pyridoxine deficient adult rat. Hypertension 11:387-391
33. Phelps CJ, Romero MI, Hurley DL (2003) Growth hormone-releasing hormone-producing and dopaminergic neurones in the mouse arcuate nucleus are independently regulated populations. J Neuroendocrinol 15:280-288
34. Plantjé JF, Schipper J, Verheijden PF, Stoof JC (1987) D2-dopamine receptors regulate the release of [3H] dopamine in rat basal hypothalamus and neurointermediate lobe of the pituitary gland. Brain Res 413:205-212
35. Salvador GA, Ilincheta de Boschero MG, Pasquaré SJ, Giusto NM (2005) Phosphatidic acid and diacylglycerol generation is regulated by insulin in cerebral cortex synaptosomes from adult and aged rats. J Neurosci Res 81:244-252. doi: 10.1002/jnr.20565
36. Scheepens A, Sirimanne E, Beilharz E, Breier BH, Waters MJ, Gluckman PD, Williams CE (1999) Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury. Brain Res Mol Brain Res 68:88-100
37. Scheepens A, Sirimanne ES, Breier BH, Clark RG, Gluckman PD, Williams CE (2001) Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 104:677-687
38. Tarazi FI, Zhang K, Baldessarini RJ (2001) Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: Implications for antipsychotic drug treatment. J Pharmacol Exp Ther 297:711-717
39. Tepper JM, Sun BC, Martin LP, Creese I (1997) Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci 17:2519-2530
40. Valverde Ignacio, Peñalva Angela, Dieguez Carlos (2000) Influence of different serotonin receptor subtypes on growth hormone secretion. Neuroendocrinology 71:145-153
41. Zhao WQ, Chen H, Quon MJ, Alkon DL (2004) Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 490:71-81. doi: 10.1016/j.ejphar.2004.02.045
42. Zoli M, Agnati LF, Tinner B, Steinbusch HW, Fuxe K (1993) Distribution of dopamine-immunoreactive neurons and their relationships to transmitter and hypothalamic hormone-immunoreactive neuronal systems in the rat mediobasal hypothalamus. A morphometric and microdensitometric analysis. J Chem Neuroanat 6:293-310